ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Glucose Monitoring (BGM) Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-28V8487
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
China Blood Glucose Monitoring BGM Market Report Forecast 2021 2027
BUY CHAPTERS

Global Blood Glucose Monitoring (BGM) Market Insights, Forecast to 2029

Code: QYRE-Auto-28V8487
Report
August 2023
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Becton
Dickinson and Co.
Terumo Corporation
ACON Laboratories Inc.
Roche Diagnostics Ltd.
Johnson & Johnson
Arkray
Novo Nordisk A S
Medtronic Inc
Abbott Laboratories
Bayer
Ypsomed
Sanofi

Blood Glucose Monitoring (BGM) Market Size

The global Blood Glucose Monitoring (BGM) market is projected to grow from US$ 8270 million in 2023 to US$ 10810 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period.

Blood Glucose Monitoring (BGM) Market

Blood Glucose Monitoring (BGM) Market

Continuous Glucose Monitoring is an advanced way for people living with diabetes to check glucose readings in real-time or monitor glucose readings over a period of time.
The U.S. market is projected to dominate the strip test segment due to the rise in the patient population, innovation in technology and health care spending while China has the highest number of self-monitoring system users. Asia Pacific and Europe are anticipated to grow over the forecast period owing to increase in some diabetic patients, lifestyle changes, increasing the prevalence of diabetes, and increasing research on diabetes and continuous innovation in technologies and its management. China is expected to witness significant growth for the BRIC diabetes device market followed by other countries such as India, Russia and Brazil.

Report Includes:

This report presents an overview of global market for Blood Glucose Monitoring (BGM), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Blood Glucose Monitoring (BGM), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Blood Glucose Monitoring (BGM), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Blood Glucose Monitoring (BGM) sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Blood Glucose Monitoring (BGM) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Blood Glucose Monitoring (BGM) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Becton, Dickinson and Co., Terumo Corporation, Acon Laboratories Inc., Roche Diagnostics Ltd., Johnson & Johnson, ARKRAY Inc., Novo Nordisk A/S and Medtronic, etc.

Scope of Blood Glucose Monitoring (BGM) Market Report

Report Metric Details
Report Name Blood Glucose Monitoring (BGM) Market
Accounted market size in 2023 US$ 8270 million
Forecasted market size in 2029 US$ 10810 million
CAGR 4.6
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Blood Glucose Meters
  • Continuous Glucose Monitoring Devices
  • Lancets
  • Blood Glucose Testing Strips
Segment by Application
  • Hospital Use
  • Clinic Use
  • Household
  • Other
Segment by Region
  • US & Canada
  • U.S.
  • Canada
  • China
  • Asia (excluding China)
  • Japan
  • South Korea
  • China Taiwan
  • Southeast Asia
  • India
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Middle East, Africa, Latin America
  • Brazil
  • Mexico
  • Turkey
  • Israel
  • GCC Countries
By Company Becton, Dickinson and Co., Terumo Corporation, Acon Laboratories Inc., Roche Diagnostics Ltd., Johnson & Johnson, ARKRAY Inc., Novo Nordisk A/S, Medtronic, Abbott Laboratories, Bayer AG, Ypsomed AG, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Blood Glucose Monitoring (BGM) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Blood Glucose Monitoring (BGM) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
  • Chapter 8: China by type, by application sales and revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Glucose Monitoring (BGM) sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Blood Glucose Monitoring (BGM) Market growing?

Ans: The Blood Glucose Monitoring (BGM) Market witnessing a CAGR of 4.6 during the forecast period 2023-2029.

What is the Blood Glucose Monitoring (BGM) Market size in 2029?

Ans: The global Blood Glucose Monitoring (BGM) market is projected to grow from US$ 8270 million in 2023 to US$ 10810 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period.

1 Study Coverage
1.1 Blood Glucose Monitoring (BGM) Product Introduction
1.2 Market by Type
1.2.1 Global Blood Glucose Monitoring (BGM) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Blood Glucose Meters
1.2.3 Continuous Glucose Monitoring Devices
1.2.4 Lancets
1.2.5 Blood Glucose Testing Strips
1.3 Market by Application
1.3.1 Global Blood Glucose Monitoring (BGM) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Blood Glucose Monitoring (BGM) Sales Estimates and Forecasts 2018-2029
2.2 Global Blood Glucose Monitoring (BGM) Revenue by Region
2.2.1 Global Blood Glucose Monitoring (BGM) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Blood Glucose Monitoring (BGM) Revenue by Region (2018-2023)
2.2.3 Global Blood Glucose Monitoring (BGM) Revenue by Region (2024-2029)
2.2.4 Global Blood Glucose Monitoring (BGM) Revenue Market Share by Region (2018-2029)
2.3 Global Blood Glucose Monitoring (BGM) Sales Estimates and Forecasts 2018-2029
2.4 Global Blood Glucose Monitoring (BGM) Sales by Region
2.4.1 Global Blood Glucose Monitoring (BGM) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Blood Glucose Monitoring (BGM) Sales by Region (2018-2023)
2.4.3 Global Blood Glucose Monitoring (BGM) Sales by Region (2024-2029)
2.4.4 Global Blood Glucose Monitoring (BGM) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Blood Glucose Monitoring (BGM) Sales by Manufacturers
3.1.1 Global Blood Glucose Monitoring (BGM) Sales by Manufacturers (2018-2023)
3.1.2 Global Blood Glucose Monitoring (BGM) Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Blood Glucose Monitoring (BGM) in 2022
3.2 Global Blood Glucose Monitoring (BGM) Revenue by Manufacturers
3.2.1 Global Blood Glucose Monitoring (BGM) Revenue by Manufacturers (2018-2023)
3.2.2 Global Blood Glucose Monitoring (BGM) Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Blood Glucose Monitoring (BGM) Revenue in 2022
3.3 Global Key Players of Blood Glucose Monitoring (BGM), Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Blood Glucose Monitoring (BGM) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Blood Glucose Monitoring (BGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Blood Glucose Monitoring (BGM), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Blood Glucose Monitoring (BGM), Product Offered and Application
3.8 Global Key Manufacturers of Blood Glucose Monitoring (BGM), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Blood Glucose Monitoring (BGM) Sales by Type
4.1.1 Global Blood Glucose Monitoring (BGM) Historical Sales by Type (2018-2023)
4.1.2 Global Blood Glucose Monitoring (BGM) Forecasted Sales by Type (2024-2029)
4.1.3 Global Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2029)
4.2 Global Blood Glucose Monitoring (BGM) Revenue by Type
4.2.1 Global Blood Glucose Monitoring (BGM) Historical Revenue by Type (2018-2023)
4.2.2 Global Blood Glucose Monitoring (BGM) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Blood Glucose Monitoring (BGM) Revenue Market Share by Type (2018-2029)
4.3 Global Blood Glucose Monitoring (BGM) Price by Type
4.3.1 Global Blood Glucose Monitoring (BGM) Price by Type (2018-2023)
4.3.2 Global Blood Glucose Monitoring (BGM) Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Blood Glucose Monitoring (BGM) Sales by Application
5.1.1 Global Blood Glucose Monitoring (BGM) Historical Sales by Application (2018-2023)
5.1.2 Global Blood Glucose Monitoring (BGM) Forecasted Sales by Application (2024-2029)
5.1.3 Global Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2029)
5.2 Global Blood Glucose Monitoring (BGM) Revenue by Application
5.2.1 Global Blood Glucose Monitoring (BGM) Historical Revenue by Application (2018-2023)
5.2.2 Global Blood Glucose Monitoring (BGM) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Blood Glucose Monitoring (BGM) Revenue Market Share by Application (2018-2029)
5.3 Global Blood Glucose Monitoring (BGM) Price by Application
5.3.1 Global Blood Glucose Monitoring (BGM) Price by Application (2018-2023)
5.3.2 Global Blood Glucose Monitoring (BGM) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Blood Glucose Monitoring (BGM) Market Size by Type
6.1.1 US & Canada Blood Glucose Monitoring (BGM) Sales by Type (2018-2029)
6.1.2 US & Canada Blood Glucose Monitoring (BGM) Revenue by Type (2018-2029)
6.2 US & Canada Blood Glucose Monitoring (BGM) Market Size by Application
6.2.1 US & Canada Blood Glucose Monitoring (BGM) Sales by Application (2018-2029)
6.2.2 US & Canada Blood Glucose Monitoring (BGM) Revenue by Application (2018-2029)
6.3 US & Canada Blood Glucose Monitoring (BGM) Market Size by Country
6.3.1 US & Canada Blood Glucose Monitoring (BGM) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Blood Glucose Monitoring (BGM) Sales by Country (2018-2029)
6.3.3 US & Canada Blood Glucose Monitoring (BGM) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Blood Glucose Monitoring (BGM) Market Size by Type
7.1.1 Europe Blood Glucose Monitoring (BGM) Sales by Type (2018-2029)
7.1.2 Europe Blood Glucose Monitoring (BGM) Revenue by Type (2018-2029)
7.2 Europe Blood Glucose Monitoring (BGM) Market Size by Application
7.2.1 Europe Blood Glucose Monitoring (BGM) Sales by Application (2018-2029)
7.2.2 Europe Blood Glucose Monitoring (BGM) Revenue by Application (2018-2029)
7.3 Europe Blood Glucose Monitoring (BGM) Market Size by Country
7.3.1 Europe Blood Glucose Monitoring (BGM) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Blood Glucose Monitoring (BGM) Sales by Country (2018-2029)
7.3.3 Europe Blood Glucose Monitoring (BGM) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Blood Glucose Monitoring (BGM) Market Size
8.1.1 China Blood Glucose Monitoring (BGM) Sales (2018-2029)
8.1.2 China Blood Glucose Monitoring (BGM) Revenue (2018-2029)
8.2 China Blood Glucose Monitoring (BGM) Market Size by Application
8.2.1 China Blood Glucose Monitoring (BGM) Sales by Application (2018-2029)
8.2.2 China Blood Glucose Monitoring (BGM) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Blood Glucose Monitoring (BGM) Market Size by Type
9.1.1 Asia Blood Glucose Monitoring (BGM) Sales by Type (2018-2029)
9.1.2 Asia Blood Glucose Monitoring (BGM) Revenue by Type (2018-2029)
9.2 Asia Blood Glucose Monitoring (BGM) Market Size by Application
9.2.1 Asia Blood Glucose Monitoring (BGM) Sales by Application (2018-2029)
9.2.2 Asia Blood Glucose Monitoring (BGM) Revenue by Application (2018-2029)
9.3 Asia Blood Glucose Monitoring (BGM) Sales by Region
9.3.1 Asia Blood Glucose Monitoring (BGM) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Blood Glucose Monitoring (BGM) Revenue by Region (2018-2029)
9.3.3 Asia Blood Glucose Monitoring (BGM) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Market Size by Type
10.1.1 Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Market Size by Application
10.2.1 Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales by Country
10.3.1 Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Becton
11.1.1 Becton Company Information
11.1.2 Becton Overview
11.1.3 Becton Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Becton Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Becton Recent Developments
11.2 Dickinson and Co.
11.2.1 Dickinson and Co. Company Information
11.2.2 Dickinson and Co. Overview
11.2.3 Dickinson and Co. Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Dickinson and Co. Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Dickinson and Co. Recent Developments
11.3 Terumo Corporation
11.3.1 Terumo Corporation Company Information
11.3.2 Terumo Corporation Overview
11.3.3 Terumo Corporation Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Terumo Corporation Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Terumo Corporation Recent Developments
11.4 Acon Laboratories Inc.
11.4.1 Acon Laboratories Inc. Company Information
11.4.2 Acon Laboratories Inc. Overview
11.4.3 Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Acon Laboratories Inc. Recent Developments
11.5 Roche Diagnostics Ltd.
11.5.1 Roche Diagnostics Ltd. Company Information
11.5.2 Roche Diagnostics Ltd. Overview
11.5.3 Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Roche Diagnostics Ltd. Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Johnson & Johnson Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 ARKRAY Inc.
11.7.1 ARKRAY Inc. Company Information
11.7.2 ARKRAY Inc. Overview
11.7.3 ARKRAY Inc. Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 ARKRAY Inc. Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ARKRAY Inc. Recent Developments
11.8 Novo Nordisk A/S
11.8.1 Novo Nordisk A/S Company Information
11.8.2 Novo Nordisk A/S Overview
11.8.3 Novo Nordisk A/S Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Novo Nordisk A/S Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novo Nordisk A/S Recent Developments
11.9 Medtronic
11.9.1 Medtronic Company Information
11.9.2 Medtronic Overview
11.9.3 Medtronic Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Medtronic Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Medtronic Recent Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Information
11.10.2 Abbott Laboratories Overview
11.10.3 Abbott Laboratories Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Abbott Laboratories Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Abbott Laboratories Recent Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Information
11.11.2 Bayer AG Overview
11.11.3 Bayer AG Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Bayer AG Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bayer AG Recent Developments
11.12 Ypsomed AG
11.12.1 Ypsomed AG Company Information
11.12.2 Ypsomed AG Overview
11.12.3 Ypsomed AG Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Ypsomed AG Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ypsomed AG Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Information
11.13.2 Sanofi Overview
11.13.3 Sanofi Blood Glucose Monitoring (BGM) Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Sanofi Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Blood Glucose Monitoring (BGM) Industry Chain Analysis
12.2 Blood Glucose Monitoring (BGM) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Blood Glucose Monitoring (BGM) Production Mode & Process
12.4 Blood Glucose Monitoring (BGM) Sales and Marketing
12.4.1 Blood Glucose Monitoring (BGM) Sales Channels
12.4.2 Blood Glucose Monitoring (BGM) Distributors
12.5 Blood Glucose Monitoring (BGM) Customers
13 Market Dynamics
13.1 Blood Glucose Monitoring (BGM) Industry Trends
13.2 Blood Glucose Monitoring (BGM) Market Drivers
13.3 Blood Glucose Monitoring (BGM) Market Challenges
13.4 Blood Glucose Monitoring (BGM) Market Restraints
14 Key Findings in The Global Blood Glucose Monitoring (BGM) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Becton
Dickinson and Co.
Terumo Corporation
ACON Laboratories Inc.
Roche Diagnostics Ltd.
Johnson & Johnson
Arkray
Novo Nordisk A S
Medtronic Inc
Abbott Laboratories
Bayer
Ypsomed
Sanofi
List of Tables
    Table 1. Global Blood Glucose Monitoring (BGM) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Table 2. Major Manufacturers of Blood Glucose Meters
    Table 3. Major Manufacturers of Continuous Glucose Monitoring Devices
    Table 4. Major Manufacturers of Lancets
    Table 5. Major Manufacturers of Blood Glucose Testing Strips
    Table 6. Global Blood Glucose Monitoring (BGM) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. Global Blood Glucose Monitoring (BGM) Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Blood Glucose Monitoring (BGM) Revenue by Region (2018-2023) & (US$ Million)
    Table 9. Global Blood Glucose Monitoring (BGM) Revenue by Region (2024-2029) & (US$ Million)
    Table 10. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Region (2018-2023)
    Table 11. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Region (2024-2029)
    Table 12. Global Blood Glucose Monitoring (BGM) Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 13. Global Blood Glucose Monitoring (BGM) Sales by Region (2018-2023) & (K Units)
    Table 14. Global Blood Glucose Monitoring (BGM) Sales by Region (2024-2029) & (K Units)
    Table 15. Global Blood Glucose Monitoring (BGM) Sales Market Share by Region (2018-2023)
    Table 16. Global Blood Glucose Monitoring (BGM) Sales Market Share by Region (2024-2029)
    Table 17. Global Blood Glucose Monitoring (BGM) Sales by Manufacturers (2018-2023) & (K Units)
    Table 18. Global Blood Glucose Monitoring (BGM) Sales Share by Manufacturers (2018-2023)
    Table 19. Global Blood Glucose Monitoring (BGM) Revenue by Manufacturers (2018-2023) & (US$ Million)
    Table 20. Global Blood Glucose Monitoring (BGM) Revenue Share by Manufacturers (2018-2023)
    Table 21. Global Key Players of Blood Glucose Monitoring (BGM), Industry Ranking, 2021 VS 2022 VS 2023
    Table 22. Blood Glucose Monitoring (BGM) Price by Manufacturers 2018-2023 (USD/Unit)
    Table 23. Global Blood Glucose Monitoring (BGM) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Blood Glucose Monitoring (BGM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Glucose Monitoring (BGM) as of 2022)
    Table 25. Global Key Manufacturers of Blood Glucose Monitoring (BGM), Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Blood Glucose Monitoring (BGM), Product Offered and Application
    Table 27. Global Key Manufacturers of Blood Glucose Monitoring (BGM), Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
    Table 30. Global Blood Glucose Monitoring (BGM) Sales by Type (2024-2029) & (K Units)
    Table 31. Global Blood Glucose Monitoring (BGM) Sales Share by Type (2018-2023)
    Table 32. Global Blood Glucose Monitoring (BGM) Sales Share by Type (2024-2029)
    Table 33. Global Blood Glucose Monitoring (BGM) Revenue by Type (2018-2023) & (US$ Million)
    Table 34. Global Blood Glucose Monitoring (BGM) Revenue by Type (2024-2029) & (US$ Million)
    Table 35. Global Blood Glucose Monitoring (BGM) Revenue Share by Type (2018-2023)
    Table 36. Global Blood Glucose Monitoring (BGM) Revenue Share by Type (2024-2029)
    Table 37. Blood Glucose Monitoring (BGM) Price by Type (2018-2023) & (USD/Unit)
    Table 38. Global Blood Glucose Monitoring (BGM) Price Forecast by Type (2024-2029) & (USD/Unit)
    Table 39. Global Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
    Table 40. Global Blood Glucose Monitoring (BGM) Sales by Application (2024-2029) & (K Units)
    Table 41. Global Blood Glucose Monitoring (BGM) Sales Share by Application (2018-2023)
    Table 42. Global Blood Glucose Monitoring (BGM) Sales Share by Application (2024-2029)
    Table 43. Global Blood Glucose Monitoring (BGM) Revenue by Application (2018-2023) & (US$ Million)
    Table 44. Global Blood Glucose Monitoring (BGM) Revenue by Application (2024-2029) & (US$ Million)
    Table 45. Global Blood Glucose Monitoring (BGM) Revenue Share by Application (2018-2023)
    Table 46. Global Blood Glucose Monitoring (BGM) Revenue Share by Application (2024-2029)
    Table 47. Blood Glucose Monitoring (BGM) Price by Application (2018-2023) & (USD/Unit)
    Table 48. Global Blood Glucose Monitoring (BGM) Price Forecast by Application (2024-2029) & (USD/Unit)
    Table 49. US & Canada Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
    Table 50. US & Canada Blood Glucose Monitoring (BGM) Sales by Type (2024-2029) & (K Units)
    Table 51. US & Canada Blood Glucose Monitoring (BGM) Revenue by Type (2018-2023) & (US$ Million)
    Table 52. US & Canada Blood Glucose Monitoring (BGM) Revenue by Type (2024-2029) & (US$ Million)
    Table 53. US & Canada Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
    Table 54. US & Canada Blood Glucose Monitoring (BGM) Sales by Application (2024-2029) & (K Units)
    Table 55. US & Canada Blood Glucose Monitoring (BGM) Revenue by Application (2018-2023) & (US$ Million)
    Table 56. US & Canada Blood Glucose Monitoring (BGM) Revenue by Application (2024-2029) & (US$ Million)
    Table 57. US & Canada Blood Glucose Monitoring (BGM) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 58. US & Canada Blood Glucose Monitoring (BGM) Revenue by Country (2018-2023) & (US$ Million)
    Table 59. US & Canada Blood Glucose Monitoring (BGM) Revenue by Country (2024-2029) & (US$ Million)
    Table 60. US & Canada Blood Glucose Monitoring (BGM) Sales by Country (2018-2023) & (K Units)
    Table 61. US & Canada Blood Glucose Monitoring (BGM) Sales by Country (2024-2029) & (K Units)
    Table 62. Europe Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
    Table 63. Europe Blood Glucose Monitoring (BGM) Sales by Type (2024-2029) & (K Units)
    Table 64. Europe Blood Glucose Monitoring (BGM) Revenue by Type (2018-2023) & (US$ Million)
    Table 65. Europe Blood Glucose Monitoring (BGM) Revenue by Type (2024-2029) & (US$ Million)
    Table 66. Europe Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
    Table 67. Europe Blood Glucose Monitoring (BGM) Sales by Application (2024-2029) & (K Units)
    Table 68. Europe Blood Glucose Monitoring (BGM) Revenue by Application (2018-2023) & (US$ Million)
    Table 69. Europe Blood Glucose Monitoring (BGM) Revenue by Application (2024-2029) & (US$ Million)
    Table 70. Europe Blood Glucose Monitoring (BGM) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 71. Europe Blood Glucose Monitoring (BGM) Revenue by Country (2018-2023) & (US$ Million)
    Table 72. Europe Blood Glucose Monitoring (BGM) Revenue by Country (2024-2029) & (US$ Million)
    Table 73. Europe Blood Glucose Monitoring (BGM) Sales by Country (2018-2023) & (K Units)
    Table 74. Europe Blood Glucose Monitoring (BGM) Sales by Country (2024-2029) & (K Units)
    Table 75. China Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
    Table 76. China Blood Glucose Monitoring (BGM) Sales by Type (2024-2029) & (K Units)
    Table 77. China Blood Glucose Monitoring (BGM) Revenue by Type (2018-2023) & (US$ Million)
    Table 78. China Blood Glucose Monitoring (BGM) Revenue by Type (2024-2029) & (US$ Million)
    Table 79. China Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
    Table 80. China Blood Glucose Monitoring (BGM) Sales by Application (2024-2029) & (K Units)
    Table 81. China Blood Glucose Monitoring (BGM) Revenue by Application (2018-2023) & (US$ Million)
    Table 82. China Blood Glucose Monitoring (BGM) Revenue by Application (2024-2029) & (US$ Million)
    Table 83. Asia Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
    Table 84. Asia Blood Glucose Monitoring (BGM) Sales by Type (2024-2029) & (K Units)
    Table 85. Asia Blood Glucose Monitoring (BGM) Revenue by Type (2018-2023) & (US$ Million)
    Table 86. Asia Blood Glucose Monitoring (BGM) Revenue by Type (2024-2029) & (US$ Million)
    Table 87. Asia Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
    Table 88. Asia Blood Glucose Monitoring (BGM) Sales by Application (2024-2029) & (K Units)
    Table 89. Asia Blood Glucose Monitoring (BGM) Revenue by Application (2018-2023) & (US$ Million)
    Table 90. Asia Blood Glucose Monitoring (BGM) Revenue by Application (2024-2029) & (US$ Million)
    Table 91. Asia Blood Glucose Monitoring (BGM) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 92. Asia Blood Glucose Monitoring (BGM) Revenue by Region (2018-2023) & (US$ Million)
    Table 93. Asia Blood Glucose Monitoring (BGM) Revenue by Region (2024-2029) & (US$ Million)
    Table 94. Asia Blood Glucose Monitoring (BGM) Sales by Region (2018-2023) & (K Units)
    Table 95. Asia Blood Glucose Monitoring (BGM) Sales by Region (2024-2029) & (K Units)
    Table 96. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales by Type (2018-2023) & (K Units)
    Table 97. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales by Type (2024-2029) & (K Units)
    Table 98. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue by Type (2018-2023) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue by Type (2024-2029) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales by Application (2018-2023) & (K Units)
    Table 101. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales by Application (2024-2029) & (K Units)
    Table 102. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue by Application (2018-2023) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue by Application (2024-2029) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 105. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue by Country (2018-2023) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue by Country (2024-2029) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales by Country (2018-2023) & (K Units)
    Table 108. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales by Country (2024-2029) & (K Units)
    Table 109. Becton Company Information
    Table 110. Becton Description and Major Businesses
    Table 111. Becton Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 112. Becton Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Becton Recent Developments
    Table 114. Dickinson and Co. Company Information
    Table 115. Dickinson and Co. Description and Major Businesses
    Table 116. Dickinson and Co. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 117. Dickinson and Co. Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Dickinson and Co. Recent Developments
    Table 119. Terumo Corporation Company Information
    Table 120. Terumo Corporation Description and Major Businesses
    Table 121. Terumo Corporation Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 122. Terumo Corporation Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Terumo Corporation Recent Developments
    Table 124. Acon Laboratories Inc. Company Information
    Table 125. Acon Laboratories Inc. Description and Major Businesses
    Table 126. Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 127. Acon Laboratories Inc. Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Acon Laboratories Inc. Recent Developments
    Table 129. Roche Diagnostics Ltd. Company Information
    Table 130. Roche Diagnostics Ltd. Description and Major Businesses
    Table 131. Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 132. Roche Diagnostics Ltd. Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Roche Diagnostics Ltd. Recent Developments
    Table 134. Johnson & Johnson Company Information
    Table 135. Johnson & Johnson Description and Major Businesses
    Table 136. Johnson & Johnson Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 137. Johnson & Johnson Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Johnson & Johnson Recent Developments
    Table 139. ARKRAY Inc. Company Information
    Table 140. ARKRAY Inc. Description and Major Businesses
    Table 141. ARKRAY Inc. Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 142. ARKRAY Inc. Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. ARKRAY Inc. Recent Developments
    Table 144. Novo Nordisk A/S Company Information
    Table 145. Novo Nordisk A/S Description and Major Businesses
    Table 146. Novo Nordisk A/S Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 147. Novo Nordisk A/S Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Novo Nordisk A/S Recent Developments
    Table 149. Medtronic Company Information
    Table 150. Medtronic Description and Major Businesses
    Table 151. Medtronic Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 152. Medtronic Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Medtronic Recent Developments
    Table 154. Abbott Laboratories Company Information
    Table 155. Abbott Laboratories Description and Major Businesses
    Table 156. Abbott Laboratories Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 157. Abbott Laboratories Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Abbott Laboratories Recent Developments
    Table 159. Bayer AG Company Information
    Table 160. Bayer AG Description and Major Businesses
    Table 161. Bayer AG Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 162. Bayer AG Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 163. Bayer AG Recent Developments
    Table 164. Ypsomed AG Company Information
    Table 165. Ypsomed AG Description and Major Businesses
    Table 166. Ypsomed AG Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 167. Ypsomed AG Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 168. Ypsomed AG Recent Developments
    Table 169. Sanofi Company Information
    Table 170. Sanofi Description and Major Businesses
    Table 171. Sanofi Blood Glucose Monitoring (BGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 172. Sanofi Blood Glucose Monitoring (BGM) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 173. Sanofi Recent Developments
    Table 174. Key Raw Materials Lists
    Table 175. Raw Materials Key Suppliers Lists
    Table 176. Blood Glucose Monitoring (BGM) Distributors List
    Table 177. Blood Glucose Monitoring (BGM) Customers List
    Table 178. Blood Glucose Monitoring (BGM) Market Trends
    Table 179. Blood Glucose Monitoring (BGM) Market Drivers
    Table 180. Blood Glucose Monitoring (BGM) Market Challenges
    Table 181. Blood Glucose Monitoring (BGM) Market Restraints
    Table 182. Research Programs/Design for This Report
    Table 183. Key Data Information from Secondary Sources
    Table 184. Key Data Information from Primary Sources
List of Figures
    Figure 1. Blood Glucose Monitoring (BGM) Product Picture
    Figure 2. Global Blood Glucose Monitoring (BGM) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Blood Glucose Monitoring (BGM) Market Share by Type in 2022 & 2029
    Figure 4. Blood Glucose Meters Product Picture
    Figure 5. Continuous Glucose Monitoring Devices Product Picture
    Figure 6. Lancets Product Picture
    Figure 7. Blood Glucose Testing Strips Product Picture
    Figure 8. Global Blood Glucose Monitoring (BGM) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 9. Global Blood Glucose Monitoring (BGM) Market Share by Application in 2022 & 2029
    Figure 10. Hospital Use
    Figure 11. Clinic Use
    Figure 12. Household
    Figure 13. Other
    Figure 14. Blood Glucose Monitoring (BGM) Report Years Considered
    Figure 15. Global Blood Glucose Monitoring (BGM) Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Blood Glucose Monitoring (BGM) Revenue 2018-2029 (US$ Million)
    Figure 17. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Region in Percentage: 2022 Versus 2029
    Figure 18. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Region (2018-2029)
    Figure 19. Global Blood Glucose Monitoring (BGM) Sales 2018-2029 ((K Units)
    Figure 20. Global Blood Glucose Monitoring (BGM) Sales Market Share by Region (2018-2029)
    Figure 21. US & Canada Blood Glucose Monitoring (BGM) Sales YoY (2018-2029) & (K Units)
    Figure 22. US & Canada Blood Glucose Monitoring (BGM) Revenue YoY (2018-2029) & (US$ Million)
    Figure 23. Europe Blood Glucose Monitoring (BGM) Sales YoY (2018-2029) & (K Units)
    Figure 24. Europe Blood Glucose Monitoring (BGM) Revenue YoY (2018-2029) & (US$ Million)
    Figure 25. China Blood Glucose Monitoring (BGM) Sales YoY (2018-2029) & (K Units)
    Figure 26. China Blood Glucose Monitoring (BGM) Revenue YoY (2018-2029) & (US$ Million)
    Figure 27. Asia (excluding China) Blood Glucose Monitoring (BGM) Sales YoY (2018-2029) & (K Units)
    Figure 28. Asia (excluding China) Blood Glucose Monitoring (BGM) Revenue YoY (2018-2029) & (US$ Million)
    Figure 29. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales YoY (2018-2029) & (K Units)
    Figure 30. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue YoY (2018-2029) & (US$ Million)
    Figure 31. The Blood Glucose Monitoring (BGM) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
    Figure 32. The Top 5 and 10 Largest Manufacturers of Blood Glucose Monitoring (BGM) in the World: Market Share by Blood Glucose Monitoring (BGM) Revenue in 2022
    Figure 33. Global Blood Glucose Monitoring (BGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 34. Global Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2029)
    Figure 35. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Type (2018-2029)
    Figure 36. Global Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2029)
    Figure 37. Global Blood Glucose Monitoring (BGM) Revenue Market Share by Application (2018-2029)
    Figure 38. US & Canada Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2029)
    Figure 39. US & Canada Blood Glucose Monitoring (BGM) Revenue Market Share by Type (2018-2029)
    Figure 40. US & Canada Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2029)
    Figure 41. US & Canada Blood Glucose Monitoring (BGM) Revenue Market Share by Application (2018-2029)
    Figure 42. US & Canada Blood Glucose Monitoring (BGM) Revenue Share by Country (2018-2029)
    Figure 43. US & Canada Blood Glucose Monitoring (BGM) Sales Share by Country (2018-2029)
    Figure 44. U.S. Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 45. Canada Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 46. Europe Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2029)
    Figure 47. Europe Blood Glucose Monitoring (BGM) Revenue Market Share by Type (2018-2029)
    Figure 48. Europe Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2029)
    Figure 49. Europe Blood Glucose Monitoring (BGM) Revenue Market Share by Application (2018-2029)
    Figure 50. Europe Blood Glucose Monitoring (BGM) Revenue Share by Country (2018-2029)
    Figure 51. Europe Blood Glucose Monitoring (BGM) Sales Share by Country (2018-2029)
    Figure 52. Germany Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 53. France Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 54. U.K. Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 55. Italy Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 56. Russia Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 57. China Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2029)
    Figure 58. China Blood Glucose Monitoring (BGM) Revenue Market Share by Type (2018-2029)
    Figure 59. China Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2029)
    Figure 60. China Blood Glucose Monitoring (BGM) Revenue Market Share by Application (2018-2029)
    Figure 61. Asia Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2029)
    Figure 62. Asia Blood Glucose Monitoring (BGM) Revenue Market Share by Type (2018-2029)
    Figure 63. Asia Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2029)
    Figure 64. Asia Blood Glucose Monitoring (BGM) Revenue Market Share by Application (2018-2029)
    Figure 65. Asia Blood Glucose Monitoring (BGM) Revenue Share by Region (2018-2029)
    Figure 66. Asia Blood Glucose Monitoring (BGM) Sales Share by Region (2018-2029)
    Figure 67. Japan Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 68. South Korea Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 69. China Taiwan Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 70. Southeast Asia Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 71. India Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 72. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales Market Share by Type (2018-2029)
    Figure 73. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue Market Share by Type (2018-2029)
    Figure 74. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales Market Share by Application (2018-2029)
    Figure 75. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue Market Share by Application (2018-2029)
    Figure 76. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Revenue Share by Country (2018-2029)
    Figure 77. Middle East, Africa and Latin America Blood Glucose Monitoring (BGM) Sales Share by Country (2018-2029)
    Figure 78. Brazil Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 79. Mexico Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 80. Turkey Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 81. Israel Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 82. GCC Countries Blood Glucose Monitoring (BGM) Revenue (2018-2029) & (US$ Million)
    Figure 83. Blood Glucose Monitoring (BGM) Value Chain
    Figure 84. Blood Glucose Monitoring (BGM) Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions